ACO Name and Location

North Texas CIN, Inc
Previous Names: N/A
17300 Dallas Parkway
Suite 3010
Dallas, TX 75248

ACO Primary Contact

Primary Contact Name

Ben Gazaway

Primary Contact Phone Number

469-250-1784

Primary Contact Email Address

bgazaway@txcin.org

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Charles Kasbarian

Y

FAMILY ORTHOPEDICS AND REHABILITATION LLP

Y

Brenda J Hampton MD PA

Y

Myint & Horton, P.A.

Y

Vijaya Nama MD PA.

Y

786 MEDICAL PLLC

Y

ERS Medical Associates of Denton

Y

Brett L. Cochrum, MD, PA

Y

THOC PA

Y

OFFICES OF FAMILY MEDICINE PLLC

Y

AULT MCINNIS PLLC

Y

Chuling Jiang, MD

Y

Charles Safely

Y

Seema Kazi MD PA

Y

David Maldonado III MD PA

Y

OMEGA HEIGHTS FAMILY MEDICINE CLINIC PLLC

Y

Internal Medicine Associates of Texas

Y

David W Carlson MD PA

Y

James R Long MD PA

Y

Douglas C. Smith, M.D., P.A.

Y

JAMES R LOW, JR., M.D.,P.A.

Y

CENTER FOR FAMILY MEDICINE,PA

Y

Charles Kasbarian, MD

Y

ABILENE INTERNIST AND ASSOCIATES PA

Y

VIRGINIA STARK-VANCE, M.D., P.A.

Y

Tarrant County CArdiology PA

Y

DR. SAMUEL C. LEE, PA

Y

MEDI CARE CLINICS PLLC

Y

ACO governing body:

Member

Member’s Voting Power – Expressed as a percentage or number

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable 

Last Name

First Name

Title/Position

Moore

John

Chair

11.11%

Non-ACO Participant

Lee

Samuel

11.11%

ACO Participant

Dr. Samuel C. Lee, PA

Culpepper

Guy

11.11%

Non-ACO Participant

Linden

Benjamin

11.11%

Non-ACO Participant

Flowers

John

11.11%

Medicare Beneficiary Representative

Gramer

Jill

11.11%

Non-ACO Participant

Selod

Faroq

11.11%

Non-ACO Participant

Schwartz

Mike

11.11%

Non-ACO Participant

Bret

Bob

11.11%

Non-ACO Participant

Key ACO clinical and administrative leadership:

Ben Gazaway

ACO Executive

Sam Lee

Medical Director

Kimberly Busenbark

Compliance Officer

Brian Casstevens, RN  

Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

Quality Improvement Care Coordination Committee

Brian Casstevens, Chair

Compliance Committee

David De Young, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

      • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

      • First Agreement Period
      • Performance Year 2017, $0

Shared Savings Distribution

      • First Agreement Period
      • Performance Year 2017
          • Proportion invested in infrastructure: N/A
          • Proportion invested in redesigned care processes/resources: N/A
          • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2017 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information 

84.28

80.60

ACO-2

CAHPS: How Well Your Providers Communicate 

93.29

93.13

ACO-3

CAHPS: Patients’ Rating of Provider 

91.19

92.31

ACO-4

CAHPS: Access to Specialists 

84.79

83.32

ACO-5

CAHPS: Health Promotion and Education

67.69

62.30

ACO-6

CAHPS: Shared Decision Making 

75.97

75.85

ACO-7

CAHPS: Health Status/Functional Status 

74.90

73.05

ACO-34

CAHPS: Stewardship of Patient Resources 

32.47

25.68

ACO-8

Risk Standardized, All Condition Readmission

14.60

15.01

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

18.14

18.46

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

52.48

53.95

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

77.67

79.16

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

62.07

61.74

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))

1.50

1.93

ACO-11

Use of Certified EHR Technology

80.00

98.48

ACO-12

Medication Reconciliation

95.31

75.32

ACO-13

Falls: Screening for Future Fall Risk 

51.08

74.38

ACO-44

Imaging Studies for Low Back Pain

71.43

67.32

ACO-14

Preventive Care and Screening: Influenza Immunization

84.12

72.52

ACO-15

Pneumonia Vaccination Status for Older Adults

71.14

72.92

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

79.03

70.69

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

58.71

90.48

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

34.11

61.98

ACO-19

Colorectal Cancer Screening

61.75

64.58

ACO-20

Breast Cancer Screening

66.89

70.05

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

74.37

79.89

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control 

15.58

16.74

ACO-41

Diabetes: Eye Exam

35.62

50.37

ACO-28

Hypertension (HTN): Controlling High Blood Pressure 

65.10

71.47

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

77.50

86.86

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “North Texas CIN, Inc” or “TXCIN” to view the quality performance results. This ACO can also be found by using the ACO ID A71094 in the public use files on data.cms.gov.

Payment Rule Waivers

    • No, our ACO does not use the SNF 3-Day Rule Waiver.
Bitnami